Published in J Pharm Pharm Sci on January 01, 2009
Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises | NCT02573714
Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system. Adv Drug Deliv Rev (2014) 1.34
Ayurvedic medicinal plants for Alzheimer's disease: a review. Alzheimers Res Ther (2012) 0.84
A new brain drug delivery strategy: focused ultrasound-enhanced intranasal drug delivery. PLoS One (2014) 0.84
Isoniazid proliposome powders for inhalation-preparation, characterization and cell culture studies. Int J Mol Sci (2011) 0.84
Recent trends in vaccine delivery systems: A review. Int J Pharm Investig (2011) 0.82
Topical Drug Delivery for Chronic Rhinosinusitis. Curr Otorhinolaryngol Rep (2012) 0.80
Mucosal vaccine delivery: Current state and a pediatric perspective. J Control Release (2016) 0.80
Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery. Drug Des Devel Ther (2013) 0.79
Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases. AAPS J (2015) 0.79
Assessment of C-phycocyanin effect on astrocytes-mediated neuroprotection against oxidative brain injury using 2D and 3D astrocyte tissue model. Sci Rep (2015) 0.78
Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice. PLoS One (2015) 0.78
Efficacy of Viola odorata in Treatment of Chronic Insomnia. Iran Red Crescent Med J (2014) 0.77
Facilitation of Drug Transport across the Blood-Brain Barrier with Ultrasound and Microbubbles. Pharmaceutics (2015) 0.77
The nasal delivery of nanoencapsulated statins - an approach for brain delivery. Int J Nanomedicine (2016) 0.77
Bioequivalence for locally acting nasal spray and nasal aerosol products: standard development and generic approval. AAPS J (2013) 0.76
Intranasal midazolam for seizure cessation in the community setting. Can Fam Physician (2016) 0.76
Focused ultrasound-enhanced intranasal brain delivery of brain-derived neurotrophic factor. Sci Rep (2016) 0.75
Optimal Volume of Administration of Intranasal Midazolam in Children: A Randomized Clinical Trial. Ann Emerg Med (2016) 0.75
Linking Suspension Nasal Spray Drug Deposition Patterns to Pharmacokinetic Profiles: A Proof-of-Concept Study Using Computational Fluid Dynamics. J Pharm Sci (2016) 0.75
Chitosan-Based Multifunctional Platforms for Local Delivery of Therapeutics. Mar Drugs (2017) 0.75
Barriers to Liposomal Gene Delivery: from Application Site to the Target. Iran J Pharm Res (2016) 0.75
Alleviation of Oxidative Damage and Involvement of Nrf2-ARE Pathway in Mesodopaminergic System and Hippocampus of Status Epilepticus Rats Pretreated by Intranasal Pentoxifylline. Oxid Med Cell Longev (2017) 0.75
Efficacy of intranasal administration of artesunate in experimental cerebral malaria. Malar J (2014) 0.75
Microarray Determination of the Expression of Drug Transporters in Humans and Animal Species Used for the Investigation of Nasal Absorption. Mol Pharm (2015) 0.75
Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception. J Pharmacol Exp Ther (2016) 0.75
Drug delivery in overcoming the blood-brain barrier: role of nasal mucosal grafting. Drug Des Devel Ther (2017) 0.75
Evaluation of Neuroprotective Effect of Thymoquinone Nanoformulation in the Rodent Cerebral Ischemia-Reperfusion Model. Biomed Res Int (2016) 0.75
Electro-physiological changes in the brain induced by caffeine or glucose nasal spray. Psychopharmacology (Berl) (2016) 0.75
Pharmacokinetics of a new, nasal formulation of naloxone. Eur J Clin Pharmacol (2017) 0.75
Intranasal midazolam administration enhances amnesic effect in rats. J Anesth (2016) 0.75
Intranasal Midazolam versus Rectal Diazepam for the Management of Canine Status Epilepticus: A Multicenter Randomized Parallel-Group Clinical Trial. J Vet Intern Med (2017) 0.75
Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies. Int J Antimicrob Agents (2012) 1.87
Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Mol Nutr Food Res (2009) 1.47
[Familial 18p syndrome -- a clinical case]. An Pediatr (Barc) (2008) 1.40
Cognitive and behavioural effects of physical exercise in psychiatric patients. Prog Neurobiol (2011) 1.18
Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects. J Clin Pharmacol (2009) 1.14
Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study. Epilepsy Res (2012) 1.03
Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review. Eur J Clin Pharmacol (2014) 1.03
Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal. Drug Saf (2012) 0.98
Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies. Epilepsia (2012) 0.98
Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers. Epilepsia (2012) 0.96
Association between white matter fiber integrity and subclinical psychotic symptoms in schizophrenia patients and unaffected relatives. Schizophr Res (2012) 0.93
Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects. J Clin Pharmacol (2005) 0.93
Safety, tolerability, and pharmacokinetics of etamicastat, a novel dopamine-β-hydroxylase inhibitor, in a rising multiple-dose study in young healthy subjects. Drugs R D (2010) 0.85
Effects of nebicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity, and motor fluctuations in patients with Parkinson disease. Clin Neuropharmacol (2008) 0.84
Single-dose tolerability, pharmacokinetics, and pharmacodynamics of etamicastat (BIA 5-453), a new dopamine β-hydroxylase inhibitor, in healthy subjects. J Clin Pharmacol (2012) 0.83
Dosage form proportionality and food effect of the final tablet formulation of eslicarbazepine acetate: randomized, open-label, crossover, single-centre study in healthy volunteers. Drugs R D (2008) 0.83
Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects. Br J Clin Pharmacol (2013) 0.82
A nonsense porcn mutation in severe focal dermal hypoplasia with natal teeth. Fetal Pediatr Pathol (2010) 0.82
Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor. Clin Pharmacokinet (2013) 0.82
Effect of eslicarbazepine acetate on the pharmacokinetics of digoxin in healthy subjects. Fundam Clin Pharmacol (2009) 0.81
CA-125 AUC as a predictor for epithelial ovarian cancer relapse. Cancer Biomark (2008) 0.81
Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique. Epilepsia (2012) 0.81
Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations. Eur J Clin Pharmacol (2014) 0.81
Third and fourth generation fluoroquinolone antibacterials: a systematic review of safety and toxicity profiles. Curr Drug Saf (2014) 0.81
Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects. Curr Med Res Opin (2010) 0.80
Liquid chromatographic methods for the quantification of catecholamines and their metabolites in several biological samples--a review. Anal Chim Acta (2012) 0.79
Effect of moderate liver impairment on the pharmacokinetics of opicapone. Eur J Clin Pharmacol (2013) 0.79
Cognitive disconnective syndrome by single strategic strokes in vascular dementia. J Neurol Sci (2012) 0.79
Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers. Epilepsia (2013) 0.79
Herb-Drug Interaction of Paullinia cupana (Guarana) Seed Extract on the Pharmacokinetics of Amiodarone in Rats. Evid Based Complement Alternat Med (2012) 0.78
First HPLC-UV method for rapid and simultaneous quantification of phenobarbital, primidone, phenytoin, carbamazepine, carbamazepine-10,11-epoxide, 10,11-trans-dihydroxy-10,11-dihydrocarbamazepine, lamotrigine, oxcarbazepine and licarbazepine in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.78
Galactosialidosis presenting as nonimmune fetal hydrops: a case report. Prenat Diagn (2009) 0.78
Investigating herb-drug interactions: the effect of Citrus aurantium fruit extract on the pharmacokinetics of amiodarone in rats. Food Chem Toxicol (2013) 0.78
Private dysferlin exon skipping mutation (c.5492G>A) with a founder effect reveals further alternative splicing involving exons 49-51. J Hum Genet (2010) 0.77
Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma. Anal Bioanal Chem (2010) 0.77
A rapid HPLC method for the simultaneous determination of amiodarone and its major metabolite in rat plasma and tissues: a useful tool for pharmacokinetic studies. J Chromatogr Sci (2012) 0.77
Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma. Biomed Chromatogr (2007) 0.77
Bioanalytical chromatographic methods for the determination of catechol-O-methyltransferase inhibitors in rodents and human samples: a review. Anal Chim Acta (2011) 0.77
Relationship between plasma and brain levels and the anticonvulsant effect of lamotrigine in rats. Eur J Pharmacol (2003) 0.77
Treatment-resistant Late-life Depression: Challenges and Perspectives. Curr Neuropharmacol (2015) 0.77
Development and validation of a fast isocratic liquid chromatography method for the simultaneous determination of norfloxacin, lomefloxacin and ciprofloxacin in human plasma. Biomed Chromatogr (2010) 0.76
Venlafaxine pharmacokinetics focused on drug metabolism and potential biomarkers. Drug Metabol Drug Interact (2014) 0.76
Disposition of eslicarbazepine acetate in the mouse after oral administration. Fundam Clin Pharmacol (2008) 0.76
First liquid chromatography method for the simultaneous determination of levofloxacin, pazufloxacin, gatifloxacin, moxifloxacin and trovafloxacin in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.76
Analytical methods for determination of new fluoroquinolones in biological matrices and pharmaceutical formulations by liquid chromatography: a review. Anal Bioanal Chem (2012) 0.76
A critical review of microextraction by packed sorbent as a sample preparation approach in drug bioanalysis. Bioanalysis (2013) 0.76
Herb-drug interaction of Fucus vesiculosus extract and amiodarone in rats: a potential risk for reduced bioavailability of amiodarone in clinical practice. Food Chem Toxicol (2012) 0.76
Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models. Epilepsy Res (2013) 0.75
Herb-drug pharmacokinetic interaction between carica papaya extract and amiodarone in rats. J Pharm Pharm Sci (2014) 0.75
First liquid chromatographic method for the simultaneous determination of amiodarone and desethylamiodarone in human plasma using microextraction by packed sorbent (MEPS) as sample preparation procedure. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.75
Vascular dementia by thalamic strategic infarct. Arq Neuropsiquiatr (2008) 0.75
Enantioselective assay for therapeutic drug monitoring of eslicarbazepine acetate: no interference with carbamazepine and its metabolites. Ther Drug Monit (2010) 0.75
Binding of licarbazepine enantiomers to mouse and human plasma proteins. Biopharm Drug Dispos (2010) 0.75
Simultaneous and enantioselective liquid chromatographic determination of eslicarbazepine acetate, S-licarbazepine, R-licarbazepine and oxcarbazepine in mouse tissue samples using ultraviolet detection. Anal Chim Acta (2007) 0.75
An HPLC-DAD method for the simultaneous quantification of opicapone (BIA 9-1067) and its active metabolite in human plasma. Analyst (2013) 0.75
Probiotics prevent growth deficit of colon wall strata of malnourished rats post-lactation. An Acad Bras Cienc (2012) 0.75
First MEPS/HPLC assay for the simultaneous determination of venlafaxine and O-desmethylvenlafaxine in human plasma. Bioanalysis (2014) 0.75
Cervical aortic arch and 22q11 deletion--the role of MRI in diagnosis. Rev Port Cardiol (2003) 0.75
Stereoselective disposition of S- and R-licarbazepine in mice. Chirality (2008) 0.75
Recent Highlights on Molecular Hybrids Potentially Useful in Central Nervous System Disorders. Mini Rev Med Chem (2016) 0.75
Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Eur J Clin Pharmacol (2008) 0.75
Chiral chromatographic resolution of antiepileptic drugs and their metabolites: a challenge from the optimization to the application. Biomed Chromatogr (2013) 0.75
A chiral liquid chromatography method for the simultaneous determination of oxcarbazepine, eslicarbazepine, R-licarbazepine and other new chemical derivatives BIA 2-024, BIA 2-059 and BIA 2-265, in mouse plasma and brain. Biomed Chromatogr (2011) 0.75
Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs. Curr Drug Metab (2016) 0.75
Chronopharmacology of nebicapone, a new catechol-O-methyltransferase inhibitor. Curr Med Res Opin (2010) 0.75